Table 1 Characteristics of patients in normoglycaemia and hyperglycaemia group at initiation of follow-up
All patients (N = 1,029) | Patients with hyperglycaemia (N = 360) | Patients without hyperglycaemia (N = 669) | Hyperglycaemia vs. normoglycaemia | |
|---|---|---|---|---|
Diagnoses (N, %) | ||||
- sepsisa | 376 | 164 (43.6%) | 202 (56.4%) | P < 0.001 |
- ACSb | 322 | 97 (30.1%) | 225 (69.9%) | |
- other diagnoses | 331 | 99 (29.9%) | 232 (70.1%) | |
Age (years) | 58 (19 to 87) | 59 (22 to 87) | 58 (19 to 86) | P = 0.214 |
Male sex (N, %) | 570 (55.4%) | 194 (53.9%) | 376 (56.2%) | P = 0.781 |
Body mass index (kg/m2) | 27.3 (17.5 to 39.8) | 29.4 (17.5 to 39.8) | 26.8 (17.6 to 38.5) | P = 0.025 |
Family history of diabetes | 108 (10.5%) | 48 (13.3%) | 60 (8.9%) | P = 0.038 |
Triglycerides (mmol/l) | 1.4 (0.9 to 4.5) | 1.4 (0.9 to 4.2) | 1.3 (0.9 to 4.5) | P = 0.106 |
Cholesterol (umol/l) | 4.5 (2.1 to 7.7) | 4.8 (2.0 to 9.7) | 4.9 (2.1 to 8.0) | P = 0.146 |
Glucose levelsc | 6.4 (2.7 to 23.5) | 7.6 (3.8 to 23.5) | 5.2 (2.7 to 7.7) | P < 0.001 |
Feeding regimen (N, %) | ||||
- enteral nutrition only | 703 (68.3%) | 248 (68.8%) | 455 (68.1%) | P = 0.823 |
- total parenteral or combination | 326 (31.7%) | 112 (31.1%) | 214 (31.9%) | |
Caloric intake (% of target) | 85% (66 to 115) | 88% (69 to 112) | 84% (67 to 113) | P = 0.541 |